You can buy or sell Immunovant and other stocks, options, ETFs, and crypto commission-free!
Immunovant, Inc. Common Stock, also called Immunovant, is a clinical-stage biopharmaceutical company. Read More It focuses on enabling normal lives for patients with autoimmune diseases. The company was founded in 2018 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low